CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 129 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $2,000 | -60.0% | 10,000 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $5,000 | 0.0% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $5,000 | -78.3% | 10,000 | 0.0% | 0.00% | -77.8% |
| Q1 2018 | $23,000 | -17.9% | 10,000 | 0.0% | 0.01% | -10.0% |
| Q4 2017 | $28,000 | -3.4% | 10,000 | 0.0% | 0.01% | -9.1% |
| Q3 2017 | $29,000 | +16.0% | 10,000 | 0.0% | 0.01% | +22.2% |
| Q2 2017 | $25,000 | -30.6% | 10,000 | 0.0% | 0.01% | -30.8% |
| Q1 2017 | $36,000 | -46.3% | 10,000 | -47.4% | 0.01% | -43.5% |
| Q4 2016 | $67,000 | -13.0% | 19,000 | 0.0% | 0.02% | -14.8% |
| Q3 2016 | $77,000 | – | 19,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KLP Enterprises, LLC | 6,865,000 | $3,096,000 | 100.00% |
| TSP Capital Management Group, LLC | 698,674 | $1,549,000 | 0.79% |
| Meditor Group Ltd | 6,312,700 | $2,847,000 | 0.61% |
| Telemetry Investments, L.L.C. | 186,200 | $84,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 1,270,500 | $573,000 | 0.03% |
| Benchmark Capital Advisors | 53,400 | $24,000 | 0.02% |
| BOENNING & SCATTERGOOD, INC. | 80,150 | $36,000 | 0.01% |
| NJ State Employees Deferred Compensation Plan | 80,000 | $36,000 | 0.01% |
| Centiva Capital, LP | 121,720 | $55,000 | 0.01% |
| Overbrook Management Corp | 48,611 | $22,000 | 0.00% |